Study: Omicron evades some but not all monoclonal antibodies

Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, researchers reported Jan. 19 in the journal Nature Medicine.

Omicron Appears to Evade Vaccines Better Than Other Variants

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6

monoclonal antibodies, VUMC Reporter

Covid-19] Omicron : resistant to most monoclonal antibodies but neutralized by a booster dose

Dominant Omicron Subvariants Better at Evading Vaccines, Antibody Treatments

Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3 - ScienceDirect

What to know about the omicron variant and subvariant BA.2 - The Washington Post

A COVID treatment wanes: New variants outsmart most monoclonal antibodies : Shots - Health News : NPR

Omicron subvariants better at evading vaccines and antibody treatments

FDA Limits Use of Monoclonal Antibodies to Treat COVID-19

Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization

Omicron evades roughly twice the number of SARS-CoV-2 neutralizing antibodies than Delta

Decoy particles trick coronavirus as it evolves - Northwestern Now

Can Covid vaccine provide immune protection against Omicron? See what latest study says